Stuart Baird, MD
Interventional Pain Medicine · Las Vegas, NVNPI 1336383504
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Abbott at 40.5% of the total. Reporting peaked in 2019 at $914 and has fallen 63.6% since, to $333 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in NV, where the typical reported total is $4,162.
Across 90 payments — averaging $36.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Nevro Corp.$762
- Boston Scientific$380
- Medtronic$268
- Si-bone, Inc.$149
- Scilex Pharmaceuticals Inc.$129
- plus $280 from 8 others
What the payments were for
- Food & beverage$3,309100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 32 | $1,340 |
| Nevro Corp. | 22 | $762 |
| Boston Scientific | 8 | $380 |
| Medtronic | 5 | $268 |
| Si-bone, Inc. | 2 | $149 |
| Scilex Pharmaceuticals Inc. | 8 | $129 |
| SPR Therapeutics, Inc | 4 | $112 |
| Forte Bio-pharma LLC | 2 | $41 |
| Nalu Medical, Inc. | 2 | $37 |
| Globus Medical | 1 | $20 |
| Biotronik NRO, Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Assertio Therapeutics, Inc. | 1 | $17 |
| Saluda Medical Americas, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,309 in reported general payments places this provider in the 40th percentile of 32 interventional pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $646 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $578 |
| Naproxen | 33 | $202 |
| Tizanidine Hcl | 43 | $189 |
| Gabapentin | 18 | $170 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Las Vegas
- Adam AntflickLas Vegas$26K
- Stephen GephardtLas Vegas$14K
- Jeremy LipshutzLas Vegas$13K
- Denys GoloshchapovLas Vegas$11K
- Edson ErkulvrawatrLas Vegas$6K
- Alafuro OrueneLas Vegas$6K
- Dolue EzeanolueLas Vegas$5K
- Katherine TravnicekLas Vegas$5K
- Godwin MadukaLas Vegas$4K
- Daniel BurkheadLas Vegas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.